Viewing Study NCT01147861


Ignite Creation Date: 2025-12-24 @ 1:03 PM
Ignite Modification Date: 2026-03-06 @ 1:24 PM
Study NCT ID: NCT01147861
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2010-06-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module